EP2817000
Lyfjasamsetningar af dabígatran etexílati til gjafar um munn
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.2.2013EP published:
4.8.2021EP application number:
13704974.8
EP translation filed:
26.10.2021Grant published:
15.11.2021EPO information:
European Patent Register
Max expiry date:
20.2.2033Expiry date:
20.2.2027Next due date:
28.2.2027
Title:
ORAL PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN ETEXILATE
Timeline
Today
21.2.2013EP application
4.8.2021EP Publication
26.10.2021Translation submitted
15.11.2021Registration published
20.2.2027Expires
Owner
Name:
TOWA PHARMACEUTICAL EUROPE, S.L.Address:
Carrer de Sant Martí, 75-97, 08107 Martorelles Barcelona, ES
Inventor
Name:
PILGAONKAR, Pratibha S.Address:
Mumbai 400 078, IN
Name:
RUSTOMJEE, Maharukh T.Address:
Mumbai 400 078, IN
Name:
GANDHI, Anilkumar S.Address:
Mumbai 400 078, IN
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
461MU2012Date:
21.2.2012Country:
IN
Classification
Categories:
A61K 9/16, A61K 9/50, A61K 31/4439, A61P 7/02, A61K 9/14, A61K 9/48
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 1.2.2022
Expires: 20.2.2023
Payer: Patice ehf.
Number: 11
Paid: 31.1.2023
Expires: 20.2.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 31.1.2023
Expires: 20.2.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 6.2.2024
Expires: 20.2.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 11.2.2025
Expires: 20.2.2026
Payer: Árnason Faktor ehf.
Number: 14
Paid: 23.2.2026
Expires: 20.2.2027
Payer: Árnason Faktor ehf.